Recombinant human granulocyte-colony stimulating factor and recombinant human macrophage-colony stimulating factor synergize in vivo to enhance proliferation of granulocyte-macrophage, erythroid, and multipotential progenitor cells in mice |
| |
Authors: | H E Broxmeyer D E Williams S Cooper G Hangoc P Ralph |
| |
Affiliation: | Department of Medicine (Hematology/Oncology), Indiana University School of Medicine, Indianapolis 46223. |
| |
Abstract: | Combinations of low dosages of purified recombinant human (rh) macrophage-colony stimulating factor (M-CSF; also termed CSF-1) and rh granulocyte-colony stimulating factor (G-CSF) were compared alone and in combination for their influence on the cycling rates and numbers of bone marrow and splenic granulocyte-macrophage, erythroid, and multipotential progenitor cells in vivo in mice pretreated with iron-saturated human lactoferrin (LF). LF was used to enhance detection of the stimulating effects of exogenously added CSFs. Concentrations of each CSF that were not active in vivo when given alone were active when given together, with the other CSF. The concentrations of rhM-CSF and rhG-CSF needed to increase progenitor cell cycling in the marrow and spleen were reduced by factors of 40-200 when these CSFs were administered in combination with low dosages of the other CSF. At the concentrations of rhM-CSF and rhG-CSF tested, synergism was not noted on absolute numbers of progenitor cells or total nucleated cell counts per organ or circulating in the blood. These findings may have potential relevance when considered in a clinical setting where the CSFs might be used in combination with other biotherapy and/or chemotherapy. |
| |
Keywords: | colony stimulating factor macrophage-colony stimulating factor granulocyte-colony stimulating factor in vivo action synergism hematopoietic progenitor cell multipotential hematopoietic progenitor cell granulocyte-macrophage progenitor cell erythroid progenitor cell lactoferrin |
|